Cited by 210Antifungal resistance and susceptibilityNosocomial Infections in ICUOcular Infections and Treatments

The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.

Empirical Fluconazole versus Placebo for Intensive Care Unit Patients: A Randomized Trial

Schuster, Mindy G., Edwards, John E., Sobel, Jack D., Darouiche, Rabih O., Karchmer, Adolf W., Hadley, Susan, Slotman, Gus, Panzer, Helene, Biswas, Pinaki, Rex, John H.·2008·Annals of Internal Medicine

DOI 10.7326/0003-4819-149-2-200807150-00004

Open this paper in CoChat — free account

Abstract

BACKGROUND: Invasive infection with Candida species is an important cause of morbidity and mortality in intensive care unit (ICU) patients. Optimal preventive strategies have not been clearly defined. OBJECTIVE: To see whether empirical fluconazole improves clinical outcomes more than placebo in adult ICU patients at high risk for invasive candidiasis. DESIGN: Double-blind, placebo-controlled, randomized trial conducted from 1995 to 2000. SETTING: 26 ICUs in the United States. PATIENTS: 270 adult ICU patients with fever despite administration of broad-spectrum antibiotics. All had central venous catheters and an Acute Physiology and Chronic Health Evaluation II score greater than 16. INTERVENTION: Patients were randomly assigned to either intravenous fluconazole, 800 mg daily, or placebo for 2 weeks and were followed for 4 weeks thereafter. Two hundred forty-nine participants were available for outcome assessment. MEASUREMENTS: A composite primary outcome that defined success as all 4 of the following: resolution of fever; absence of invasive fungal infection; no discontinuation because of toxicity; and no need for a nonstudy, systemic antifungal medication (as assessed by a blinded oversight committee). RESULTS: Only 44 of 122 (36%) fluconazole recipients and 48 of 127 (38%) placebo recipients had a successful outcome (relative risk, 0.95 [95% CI, 0.69 to 1.32; P = 0.78]). The main reason for failure was lack of resolution of fever (51% for fluconazole and 57% for placebo). Documented invasive candidiasis occurred in 5% of fluconazole recipients and 9% of placebo recipients (relative risk, 0.57 [CI, 0.22 to 1.49]). Seven (5%) fluconazole recipients and 10 (7%) placebo recipients had adverse events resulting in discontinuation of the study drug. Discontinuation because of abnormal liver test results occurred in 3 (2%) fluconazole recipients and 5 (4%) placebo recipients. LIMITATIONS: Twenty-one randomly assigned patients were not included in the analysis because they either did not meet entry criteria or did not have postbaseline assessments. Fewer fungal infections than anticipated occurred in the control group. Confidence bounds were wide and did not exclude potentially important differences in outcomes between groups. CONCLUSION: In critically ill adults with risk factors for invasive candidiasis, empirical fluconazole did not clearly improve a composite outcome more than placebo.

Integrity signals

Registry

Crossref · 10.7326/0003-4819-149-2-200807150-00004

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Prevalence of Nosocomial Infection in Intensive Care Units in Europe
Vincent, J. (1995) · JAMA · doi:10.1001/jama.274.8.639 · Cited by 2,592
A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Self-citation
Increase in Candida krusei Infection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole
Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251803 · Cited by 937
Resistance of Candida species to fluconazole
Rex, J. H., Rinaldi, M. G., & Pfaller, M. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.1 · Cited by 880
Self-citation
Hospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831
Management of Fever in Patients with Cancer and Treatment-Induced Neutropenia
Wood, A. J. J., & Pizzo, P. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305063281808 · Cited by 831
Candida Colonization and Subsequent Infections in Critically III Surgical Patients
Pittet, D., Monod, M., Suter, P. M., Frenk, E., & Auckenthaler, R. (1994) · Annals of Surgery · doi:10.1097/00000658-199412000-00008 · Cited by 798
The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis
Zaoutis, T. E., Argon, J., Chu, J., Berlin, J. A., Walsh, T. J., & Feudtner, C. (2005) · Clinical Infectious Diseases · doi:10.1086/496922 · Cited by 784
The Epidemiology of Hematogenous Candidiasis Caused by Different Candida Species
Abi‐Said, D., Anaissie, E., Uzun, O., Raad, I., Pinzcowski, H., & Vartivarian, S. (1997) · Clinical Infectious Diseases · doi:10.1086/513663 · Cited by 755
1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
Hughes, W. T., Armstrong, D., Bodey, G. P., Brown, A. E., Edwards, J. E., Feld, R. D., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., & Young, L. S. (1997) · Clinical Infectious Diseases · doi:10.1086/513764 · Cited by 664
Self-citation

Show all 28 references

Research works printed but not linked: 1

10.1001/jama.1995.03530080055041 · DOI

Sorted by citations

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Self-citation
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Self-citation
Invasive candidiasis
Pappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L., & Kullberg, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.26 · Cited by 1,636
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
Cornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217
Candida Infections of the Genitourinary Tract
Achkar, J. M., & Fries, B. C. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00076-09 · Cited by 736
Finding the “Missing 50%” of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care
Clancy, C. J., & Nguyen, M. H. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit006 · Cited by 688
An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients
LIMPER, A. H., Knox, K. S., Sarosi, G. A., Ampel, N. M., Bennett, J. E., Catanzaro, A., Davies, S. F., Dismukes, W. E., Hage, C. A., Marr, K. A., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2008-740st · Cited by 612
Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study*
Kett, D. H., Azoulay, E., Echeverria, P. M., & Vincent, J.-L. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318206c1ca · Cited by 389
Invasive candidiasis as a cause of sepsis in the critically ill patient
Delaloye, J., & Calandra, T. (2013) · Virulence · doi:10.4161/viru.26187 · Cited by 395
ESCMID guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.
Hope, W. W., Castagnola, E., Groll, A. H., Roilides, E., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., Bassetti, M., Bille, J., Cornely, O. A., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12040 · Cited by 360
Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention
Alangaden, G. J. (2011) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.11.003 · Cited by 337
EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group
Bassetti, M., Azoulay, É., Kullberg, B. J., Ruhnke, M., Shoham, S., Vázquez, J. A., Giacobbe, D. R., & Calandra, T. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1751 · Cited by 347
Invasive Candidiasis
McCarty, T. P., & Pappas, P. G. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.013 · Cited by 285
Candidemia and Invasive Candidiasis
McCarty, T. P., White, C. M., & Pappas, P. G. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.007 · Cited by 260
ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients
Martín‐Loeches, I., Antonelli, M. M., Cuenca‐Estrella, M., Dimοpoulos, G., Einav, S., Waele, J. J. D., Garnacho‐Montero, J., Kanj, S. S., Machado, F. R., Montravers, P., et al. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05599-w · Cited by 238
Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology
Cornely, O. A., Hoenigl, M., Lass‐Flörl, C., Chen, S. C. ‐., Kontoyiannis, D. P., Morrissey, C. O., & Thompson, G. R. (2019) · Mycoses · doi:10.1111/myc.12960 · Cited by 229
Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial
Timsit, J.-F., Azoulay, E., Schwebel, C., Charles, P. E., Cornet, M., Souweine, B., Klouche, K., Jaber, S., Trouillet, J.-L., Bruneel, F., et al. (2016) · JAMA · doi:10.1001/jama.2016.14655 · Cited by 198
Intensive care medicine research agenda on invasive fungal infection in critically ill patients
Bassetti, M., Garnacho‐Montero, J., Calandra, T., Kullberg, B. J., Dimοpoulos, G., Azoulay, É., Chakrabarti, A., Kett, D., León, C., Ostrosky-Zeichner, L. L., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4731-2 · Cited by 188
Invasive Fungal Infections in the ICU: How to Approach, How to Treat
Paramythiotou, E., Frantzeskaki, F. G., Flevari, A., Armaganidis, A., & Dimοpoulos, G. (2014) · Molecules · doi:10.3390/molecules19011085 · Cited by 181
Candida infections in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
Aslam, S., Rotstein, C., & Practice, T. A. I. D. C. O. (2019) · Clinical Transplantation · doi:10.1111/ctr.13623 · Cited by 169
Nosocomial Fungal Infections
Anaissie, E. J., & Bodey, G. P. (1989) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30311-1 · Cited by 159
Overview of Antifungal Agents
Thompson, G. R., Cadena, J., & Patterson, T. F. (2009) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2009.02.001 · Cited by 142
Nosocomial Fungal Infections
Suleyman, G., & Alangaden, G. J. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.07.008 · Cited by 141
Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy
Ruhnke, M., Rickerts, V., Cornely, O. A., Buchheidt, D., Glöckner, A., Heinz, W., Höhl, R., Horré, R., Karthaus, M., Kujath, P., et al. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02040.x · Cited by 140
Systemic antifungal therapy in critically ill patients without invasive fungal infection*
Azoulay, É., Dupont, H., Tabah, A., Lortholary, O., Stahl, J. ‐., Français, A., Martin, C., Guidet, B., & Timsit, J. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318236f297 · Cited by 136
Diagnosis of invasive candidiasis in the ICU
Eggimann, P., Billé, J., & Marchetti, O. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-37 · Cited by 138
Risk Factors for Fluconazole-Resistant Candidemia
Garnacho‐Montero, J., Díaz‐Martín, A., García-Cabrera, E., de Pipaón, M. R. P., Hernandez-Caballero, C., Aznar, J., Cisneros, J. M., & Ortíz-Leyba, C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00479-10 · Cited by 128
Sepsis: Current Definition, Pathophysiology, Diagnosis, and Management
Taeb, A. M., Hooper, M. H., & Marik, P. E. (2017) · Nutrition in Clinical Practice · doi:10.1177/0884533617695243 · Cited by 133
β-D-glucan Surveillance with Preemptive Anidulafungin for Invasive Candidiasis in Intensive Care Unit Patients: A Randomized Pilot Study
Hanson, K. E., Pfeiffer, C. D., Lease, E. D., Balch, A. H., Zaas, A. K., Perfect, J. R., & Alexander, B. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042282 · Cited by 124
Gut Leakage of Fungal-Derived Inflammatory Mediators: Part of a Gut-Liver-Kidney Axis in Bacterial Sepsis
Amornphimoltham, P., Yuen, P. S. T., Star, R. A., & Leelahavanichkul, A. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05581-y · Cited by 109
A Randomized, Placebo-controlled Trial of Preemptive Antifungal Therapy for the Prevention of Invasive Candidiasis Following Gastrointestinal Surgery for Intra-abdominal Infections
Knitsch, W., Vincent, J., Utzolino, S., François, B., Dinya, T., Dimοpoulos, G., Özgüneş, İ., Valía, J. C., Eggimann, P., León, C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ707 · Cited by 101
The current treatment landscape: Candidiasis
Bassetti, M., Peghin, M., & Timsit, J.-F. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw392 · Cited by 99
What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead
Bassetti, M., Righi, E., Montravers, P., & Cornely, O. A. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx445 · Cited by 102
Early treatment of candidemia in adults: a review
Ostrosky-Zeichner, L., Kullberg, B. J., Bow, E. J., Hadley, S., León, C., Nucci, M., Patterson, T. F., & Perfect, J. R. (2011) · Medical Mycology · doi:10.3109/13693786.2010.512300 · Cited by 97
Self-citation
The Japanese guidelines for the management of sepsis
Oda, S., Aibiki, M., Ikeda, T., Imaizumi, H., Endo, S., Ochiai, R., Kotani, J., Shime, N., Nishida, O., Noguchi, T., et al. (2014) · Journal of Intensive Care · doi:10.1186/s40560-014-0055-2 · Cited by 93
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients
Cortegiani, A., Russotto, V., Maggiore, A., Attanasio, M., Naro, A. R., Raineri, S. M., & Giarratano, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004920.pub3 · Cited by 91
Supplement: Trends in invasive Candida infections and their treatment: focus on echinocandins
Lewis, R. E. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990902990817 · Cited by 89
Antifungal stewardship in invasive Candida infections
Ruhnke, M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12622 · Cited by 90
Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case-control study
Hermsen, E. D., Zapapas, M. K., Maiefski, M., Rupp, M. E., Freifeld, A. G., & Kalil, A. C. (2011) · Critical Care · doi:10.1186/cc10366 · Cited by 83
Invasive fungal infections in patients with cancer in the Intensive Care Unit
Sipsas, N. V., & Kontoyiannis, D. P. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.11.017 · Cited by 82
Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients
Senn, L., Eggimann, P., Ksontini, R., Pascual, A., Demartines, N., Billé, J., Calandra, T., & Marchetti, O. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1405-8 · Cited by 81
Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. – Trends over 10 years
Bailly, S., Maubon, D., Fournier, P., Pelloux, H., Schwebel, C., Chapuis, C., Foroni, L., Cornet, M., & Timsit, J. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.09.041 · Cited by 81
Invasive Fungal Infections in the Intensive Care Unit
Ostrosky-Zeichner, L., & Al-Obaidi, M. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.05.005 · Cited by 76
Preventing invasive candida infections. Where could we do better?
Eggimann, P., Que, Y., Revelly, J., & Pagani, J. (2014) · Journal of Hospital Infection · doi:10.1016/j.jhin.2014.11.006 · Cited by 76
European expert opinion on the management of invasive candidiasis in adults
Kullberg, B. J., Verweij, P. E., Akova, M., Arendrup, M. C., Billé, J., Calandra, T., Cuenca‐Estrella, M., Herbrecht, R., Jacobs, F., Kalin, M., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03615.x · Cited by 72
Self-citation
Occurrence, presentation and treatment of candidemia
Mikulska, M., Del Bono, V., Ratto, S., & Viscoli, C. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.52 · Cited by 71
Canadian Clinical Practice Guidelines for Invasive Candidiasis in Adults
Bow, E. J., Evans, G. A., Fuller, J., Laverdière, M., Rotstein, C., Rennie, R. P., Shafran, S. D., Sheppard, D. C., Carle, S., Phillips, P., et al. (2010) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2010/357076 · Cited by 70
Discontinuation of empirical antifungal therapy in ICU patients using 1,3-β-d-glucan
Nucci, M., Nouér, S. A., Esteves, P., Guimarães, T., Breda, G. L., de Miranda, B. G., Queiroz‐Telles, F., & Colombo, A. L. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw188 · Cited by 67
Candidemia in the Intensive Care Unit
Epelbaum, O., & Chasan, R. (2017) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2017.04.010 · Cited by 67
Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting
Lepak, A., & Andes, D. (2011) · Critical Care Clinics · doi:10.1016/j.ccc.2010.11.001 · Cited by 62
(1 → 3)-β-d-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial
Bloos, F., Held, J., Kluge, S., Simon, P., Kogelmann, K., de Heer, G., Kuhn, S., Jarczak, D., Motsch, J., Hempel, G., et al. (2022) · Intensive Care Medicine · doi:10.1007/s00134-022-06733-x · Cited by 62
Failure of Empirical Systemic Antifungal Therapy in Mechanically Ventilated Critically Ill Patients
Bailly, S., Bouadma, L., Azoulay, É., Garrouste-Orgeas, M., Adrie, C., Souweine, B., Schwebel, C., Maubon, D., Hamidfar-Roy, R., Darmon, M., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201409-1701oc · Cited by 63
Persistent organ dysfunction plus death: a novel, composite outcome measure for critical care trials
Heyland, D. K., Muscedere, J., Drover, J., Jiang, X., Day, A. G., & the Canadian Critical Care Trials Group (2011) · Critical Care · doi:10.1186/cc10110 · Cited by 56
Diagnosis and Treatment of Candidemia in the Intensive Care Unit
Bassetti, M., Giacobbe, D. R., Vena, A., & Wolff, M. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1693704 · Cited by 56
Invasive Fungal Infections in the ICU
Shoham, S., & Marwaha, S. (2009) · Journal of Intensive Care Medicine · doi:10.1177/0885066609355262 · Cited by 55
Opportunistic Fungi: A View to the Future
Pappas, P. G. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181e99c88 · Cited by 50
The Effect of Inadequate Initial Empiric Antimicrobial Treatment on Mortality in Critically Ill Patients with Bloodstream Infections: A Multi-Centre Retrospective Cohort Study
Savage, R., Fowler, R., Rishu, A. H., Bagshaw, S. M., Cook, D., Dodek, P., Hall, R., Kumar, A., Lamontagne, F., Lauzier, F., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154944 · Cited by 49
Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region
Hsueh, P., Graybill, J. R., Playford, E. G., Watcharananan, S. P., Oh, M., Jaalam, K., Huang, S., Nangia, V., Kurup, A., & Padiglione, A. A. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.03.014 · Cited by 48
Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation
Poissy, J., Sendid, B., Damiens, S., Ishibashi, K. I., François, N., Kauv, M., Favory, R., Mathieu, D., & Poulain, D. (2014) · Critical Care · doi:10.1186/cc13953 · Cited by 49
Infectious Complications Following Solid Organ Transplantation
Guenette, A., & Husain, S. (2018) · Critical Care Clinics · doi:10.1016/j.ccc.2018.08.004 · Cited by 45
Invasive Candida Infections and the Harm From Antibacterial Drugs in Critically Ill Patients
Jensen, J. S., Hein, L., Lundgren, B., Bestle, M. H., Mohr, T. T., Andersen, M. H., Løken, J., Tousi, H., Søe‐Jensen, P., Lauritsen, A. Ø., et al. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000746 · Cited by 45
Fungal infections in the ICU
Zilberberg, M. D., & Shorr, A. F. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2009.04.008 · Cited by 42
Prophylaxis, empirical and preemptive treatment of invasive candidiasis
Playford, E. G., Lipman, J., & Sorrell, T. C. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e10e8 · Cited by 41
An Italian consensus for invasive candidiasis management (ITALIC)
Scudeller, L., Viscoli, C., Menichetti, F., Bono, V. D., Cristini, F., Tascini, C., Bassetti, M., & Viale, P. (2013) · Infection · doi:10.1007/s15010-013-0558-0 · Cited by 42
Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation
Zilberberg, M. D., Kothari, S., & Shorr, A. F. (2009) · Critical Care · doi:10.1186/cc7924 · Cited by 41
Treatment of Invasive Pulmonary Aspergillosis and Preventive and Empirical Therapy for Invasive Candidiasis in Adult Pulmonary and Critical Care Patients: An Official American Thoracic Society Clinical Practice Guideline
Epelbaum, O., Marinelli, T. M., Haydour, Q., Pennington, K. M., Evans, S. E., Carmona, E. M., Husain, S., Knox, K. S., Jarrett, B. J., Azoulay, É., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202410-2045st · Cited by 45
Fungal infections in the ICU
PASCALE, G. D., & Tumbarello, M. (2015) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000230 · Cited by 39
Cost-Effectiveness Analysis of Multiplex PCR with Magnetic Resonance Detection versus Empiric or Blood Culture-Directed Therapy for Management of Suspected Candidemia
Walker, B. S., Powers‐Fletcher, M. V., Schmidt, R. L., & Hanson, K. E. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.02971-15 · Cited by 37
Candida Colonization and Candiduria in Critically Ill Patients in the Intensive Care Unit
Viale, P. (2009) · Drugs · doi:10.2165/11315640-000000000-00000 · Cited by 36
Fungal infections in severe acute pancreatitis
Kochhar, R. K., Noor, M. T., & Wig, J. D. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06685.x · Cited by 37
Neutropenic Enterocolitis in Critically Ill Patients: Spectrum of the Disease and Risk of Invasive Fungal Disease
Duceau, B., Picard, M., Pirracchio, R., Wanquet, A., Pène, F., Merceron, S., Mokart, D., Moreau, A., Lengliné, É., Canet, E., et al. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003687 · Cited by 35
Epidemiology and management of candidaemia - a retrospective, multicentre study in five hospitals in the UK
Chalmers, C., Gaur, S., Chew, J. L. L., Wright, T., Kumar, A., Mathur, S., Wan, W., Gould, I. M., Leanord, A., & Bal, A. M. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02027.x · Cited by 36
Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin
Imtiaz, T., Lee, K. K., Munro, C. A., MacCallum, D. M., Shankland, G. S., Johnson, E. M., MACGREGOR, M. S., & Bal, A. M. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.045047-0 · Cited by 32
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
Mikulska, M., Bassetti, M., Ratto, S., & Viscoli, C. (2011) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2011.007 · Cited by 32
How to select an antifungal agent in critically ill patients
Dimοpoulos, G., Antonopoulou, A., Armaganidis, A., & Vincent, J. (2013) · Journal of Critical Care · doi:10.1016/j.jcrc.2013.04.006 · Cited by 33
Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU
Bruyère, R., Quenot, J., Prin, S., Dalle, F., Vigneron, C., Aho, S., León, C., & Charles, P. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-385 · Cited by 32
Early antifungal intervention strategies in ICU patients
Eggimann, P., & Ostrosky‐Zeichner, L. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e0487 · Cited by 29
Management of Invasive Candidiasis in the Intensive Care Unit
Playford, E. G., Lipman, J., & Sorrell, T. C. (2010) · Drugs · doi:10.2165/10898550-000000000-00000 · Cited by 29
Coping with Candida Infections
Evans, S. E. (2010) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200907-075al · Cited by 27
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025
Brunkhorst, F. M., Adamzik, M., Axer, H., Bauer, M. W., Bode, C., Bone, H.-G., Brenner, T., Bucher, M., David, S., Dietrich, M., et al. (2025) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-025-01317-1 · Cited by 35
Antifungal therapy in European hospitals: data from the ESAC point-prevalence surveys 2008 and 2009
Zarb, P., Amadéo, B., Muller, A., Drapier, N., Vankerckhoven, V., Davey, P. G., & Goossens, H. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03973.x · Cited by 28
Antifungal stewardship with an emphasis on candidaemia
Capoor, M. R., Subudhi, C. P. K., Collier, A., & Bal, A. M. (2019) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2019.05.030 · Cited by 27
The paradox of the evidence about invasive fungal infections prevention
Cortegiani, A., Russotto, V., Raineri, S. M., & Giarratano, A. (2016) · Critical Care · doi:10.1186/s13054-016-1284-7 · Cited by 25
Candidiasis
Vázquez, J. A., & Sobel, J. D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_11 · Cited by 26
Self-citation
Candida in the ICU
Darouiche, R. O. (2009) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2009.02.013 · Cited by 23
Self-citation
Evolving role of early antifungals in the adult intensive care unit
Lam, S. W., Eschenauer, G. A., & Carver, P. L. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819dec9b · Cited by 23
Invasive Candidiasis in the Intensive Care Unit: Where Are We Now?
Vázquez, J. A., Whitaker, L., & Zubovskaia, A. (2025) · Journal of Fungi · doi:10.3390/jof11040258 · Cited by 26
Current aspects of invasive candidiasis and aspergillosis in adult intensive care patients
Glöckner, A., & Karthaus, M. (2010) · Mycoses · doi:10.1111/j.1439-0507.2010.01885.x · Cited by 23
De-escalation of antifungal treatment in critically ill patients with suspected invasive Candida infection: incidence, associated factors, and safety
Jaffal, K., Poissy, J., Rouzé, A., Préau, S., Sendid, B., Cornu, M., & Nseir, S. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0392-8 · Cited by 24
Invasive Candidiasis
Schroeder, J. A., Wilson, C. M., & Pappas, P. G. (2024) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2024.11.007 · Cited by 26
Anidulafungin for the treatment of invasive candidiasis
Mayr, A., Aigner, M., & Lass‐Flörl, C. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03448.x · Cited by 21
Outcomes associated with routine systemic antifungal therapy in critically ill patients with Candida colonization
Ferreira, D., Grenouillet, F., Blasco, G., Samain, E., Hénon, T., Dussaucy, A., Millon, L., Mercier, M., & Pili‐Floury, S. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3791-4 · Cited by 22
Antifungal Prevention of Systemic Candidiasis in Immunocompetent ICU Adults: Systematic Review and Meta-Analysis of Clinical Trials
Dupont, H., Mahjoub, Y., Chouaki, T., Lorne, E., & Zogheib, E. H. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002698 · Cited by 21
Impact of microbiome-based interventions on gastrointestinal pathogen colonization in the intensive care unit
Choy, A. M., & Freedberg, D. E. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820939447 · Cited by 22
Oral nystatin prophylaxis in surgical/trauma ICU patients: a randomised clinical trial
Giglio, M., Caggiano, G., Dalfino, L., Brienza, N., Alicino, I., Sgobio, A., Favale, A., Coretti, C., Montagna, M. T., Bruno, F., et al. (2012) · Critical Care · doi:10.1186/cc11300 · Cited by 20
Mind the gaps: challenges in the clinical management of invasive candidiasis in critically ill patients
Pietrobom, P. M. P., & Colombo, A. L. (2020) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000684 · Cited by 20
Empirical Fluconazole versus Placebo for Intensive Care Unit Patients: A Randomized Trial
Kumar, A. (2009) · Yearbook of Critical Care Medicine · doi:10.1016/s0734-3299(08)79029-4 · Cited by 20
Candida endocarditis: Update on management considerations
Jamil, Y., Akinleye, A. A., Mirzaei, M., Lempel, M., Farhat, K., & Pan, S. (2023) · World Journal of Cardiology · doi:10.4330/wjc.v15.i10.469 · Cited by 21
Combined use of nonculture-based lab techniques in the diagnosis and management of critically ill patients with invasive fungal infections
Pemán, J., & Zaragoza, R. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.128 · Cited by 19
EMPIRICUS micafungin versus placebo during nosocomial sepsis in Candida multi-colonized ICU patients with multiple organ failures: study protocol for a randomized controlled trial
Timsit, J., Azoulay, É., Cornet, M., Gangneux, J., Jullien, V., Vesin, A., Schir, É., & Wolff, M. (2013) · Trials · doi:10.1186/1745-6215-14-399 · Cited by 19

Authors: Schuster, M. G., Edwards, J. E., Sobel, J. D., Darouiche, R. O., Karchmer, A. W., Hadley, S., Slotman, G., Panzer, H., Biswas, P., & Rex, J. H.
Affiliations: Tufts Medical Center (US)
Tufts University (US)
AstraZeneca (United Kingdom) (GB)
ORCID: Schuster, Mindy G.
Edwards, John E.
Karchmer, Adolf W.
Hadley, Susan
Biswas, Pinaki
Rex, John H.
Venue: Annals of Internal Medicine
Publisher: American College of Physicians
Published: 2008-07-15
Volume: 149
Issue: 2
Pages: 83-90
ISSN: 0003-4819 (ISSN-L)
1539-3704
DOI: 10.7326/0003-4819-149-2-200807150-00004
OpenAlex: W2041927838
Semantic Scholar: 7f6c28e24e62a031b9fbd07664f827cb67f8e714
Cited by: 210
References: 28
Citations by year: 2026: 7 · 2025: 4 · 2024: 3 · 2023: 6 · 2022: 5 · 2021: 3 · 2020: 5 · 2019: 14 · 2018: 7 · 2017: 15 · 2016: 12 · 2015: 14 · 2014: 20 · 2013: 11 · 2012: 16
FWCI: 14.30
Type: journal article
Language: en
Open access: closed
Licence: www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations: Annals of Internal Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: Pfizer
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
Keywords: invasive candidiasis, fluconazole, intensive care unit patients, critically ill adults, central venous catheters, APACHE II score, antifungal toxicity, liver function tests, composite endpoints, treatment discontinuation, ICU length of stay, cost-effectiveness
MeSH terms: Adult, Aged, Antifungal Agents, Candidiasis, Critical Care, Cross Infection, Double-Blind Method, Female, Follow-Up Studies, Humans, Intensive Care Units, Male, Middle Aged, Risk Factors, Fluconazole, Fungemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Empirical Fluconazole versus Placebo for Intensive Care Unit Patients: A Randomized Trial

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks